Ms. Tina A Shroff, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1021 E Sibley Blvd, Dolton, IL 60419 Phone: 708-849-9520 Fax: 908-849-9584 |
Dr. Lee B Silverglade, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1350 E Sibley Blvd, Ste 302, Dolton, IL 60419 Phone: 708-849-4644 |
David E Miller, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1218 E Sibley Blvd, Dolton, IL 60419 Phone: 708-841-3333 |
Dr. James Anthony Matchus, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1121 E Sibley Blvd, Dolton, IL 60419 Phone: 708-841-3565 |
Dr. Mustapha Hotait, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 1350 E Sibley Blvd, Suite 302, Dolton, IL 60419 Phone: 708-849-4644 |
Dr. Dean Duval Dietrich, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 609 E Sibley Blvd, Dolton, IL 60419 Phone: 708-849-4400 |
Dr. Paul Theodore Anast, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1121 E Sibley Blvd, Dolton, IL 60419 Phone: 708-201-1072 |
News Archive
Today is the official launch of a newly formed Coalition of medical, mental health, higher education, student and pharmaceutical organizations that will work together to help prevent misuse, abuse and diversion of ADHD prescription stimulant medication. The Coalition will initially focus its efforts on college students.
Researchers report for the first time that genetic variants in mitochondria,energy-producing structures harboring DNA that are inherited only from the mother,are directly linked to metabolic markers for type 2 diabetes.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.
› Verified 1 days ago